ArticleThe Pan African medical journal2025
Short-term treatment of multidrug-resistant tuberculosis: a multicenter study of therapeutic effectiveness and adverse drug reactions in Yogyakarta, Indonesia.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study analyzed the therapeutic effectiveness, ADRs, and their influencing factors in multidrug-resistant tuberculosis (MDR-TB) patients. We conducted a cross-sectional study involving patients in four referral hospitals in Yogyakarta province. The data was collected from the medical records and the Tuberculosis Information System (SITB) of the Ministry of Health of the Republic of Indonesia from January 2020 to June 2023. Of the 65 patients, 31 (47.7%) showed the expected clinical response. The factors affecting the therapeutic effectiveness were occupation and medication adherence. The most frequent ADR found was gastrointestinal disorders (19.9%). Based on the severity levels, the most frequently found ADRs were levels 1 and 3, at 60.1% and 26.1%, respectively. In conclusion, more than half of all the MDR-TB patients still showed an inadequate clinical response, with almost 40% of MDR-TB patients experiencing ADRs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.